Detalhe da pesquisa
1.
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
BJU Int;
132(2): 188-195, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36855895
2.
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.
Prostate;
82(15): 1469-1476, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35971798
3.
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer.
Clin Proteomics;
19(1): 9, 2022 Apr 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35477343
4.
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.
BJU Int;
123(5): 826-833, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30216634
5.
N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.
Mol Cell Proteomics;
12(4): 1005-16, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23408683
6.
Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer.
Proc Natl Acad Sci U S A;
108(8): 3342-7, 2011 Feb 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21300890
7.
Evaluation of Proclarix in the diagnostic work-up of prostate cancer.
BJUI Compass;
5(2): 297-303, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38371198
8.
PASSEL: the PeptideAtlas SRMexperiment library.
Proteomics;
12(8): 1170-5, 2012 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22318887
9.
Comprehensive description of the N-glycoproteome of mouse pancreatic ß-cells and human islets.
J Proteome Res;
11(3): 1598-608, 2012 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22148984
10.
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
Eur Urol Oncol;
5(3): 321-327, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33422560
11.
On the development of plasma protein biomarkers.
J Proteome Res;
10(1): 5-16, 2011 Jan 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21142170
12.
Analysis of cell surface proteome changes via label-free, quantitative mass spectrometry.
Mol Cell Proteomics;
8(4): 624-38, 2009 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19036722
13.
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
PLoS One;
16(11): e0259093, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34767586
14.
Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer.
BJUI Compass;
1(1): 15-20, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35474911
15.
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
PLoS One;
15(5): e0233442, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32421745
16.
Similarities and Differences of Blood N-Glycoproteins in Five Solid Carcinomas at Localized Clinical Stage Analyzed by SWATH-MS.
Cell Rep;
23(9): 2819-2831.e5, 2018 05 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29847809
17.
Direct selection of antibodies from complex libraries with the protein fragment complementation assay.
J Mol Biol;
357(2): 427-41, 2006 Mar 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16442560
18.
Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.
PLoS One;
12(8): e0181557, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28767721
19.
A mass spectrometric-derived cell surface protein atlas.
PLoS One;
10(3): e0121314, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25894527
20.
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09).
Eur Urol;
66(3): 468-74, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24412228